
Please try another search
With the advent of the COVID-19 omicron variant, vaccine developers are again the recipients of heightened investor attention. The success of Pfizer’s (PFE) and BioNTech’s (BNTX) COVID-19 vaccines has helped these stocks soar in price over the past few months, and they could continue gaining. So, we think it could be wise to add them to one’s portfolio now. Read on.Discovered only a few weeks ago, the COVID-19 omicron variant is now the dominant strain in the United States, accounting for roughly 73% of cases. The Biden administration has been taking steps to contain its spread. Last month, the White House's COVID-19 response coordinator, Jeff Zients, said, “We're working with Pfizer , Moderna (NASDAQ:MRNA), and (Johnson & Johnson) to develop contingency plans for modifications to vaccines or boosters if they're needed.”
With the rapid spread of the new variant across several parts of the world, the demand for COVID-19 vaccines and booster shots is expected to increase significantly. According to a BCC Research report, the global market for vaccine technologies is expected to grow at a 7.6% CAGR over the next five years to $55.10 billion.
Therefore, we think it could be wise to bet on quality COVID-19 vaccine stocks Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX). They have gained significantly in price, especially with the emergence of the omicron variant. And these stocks are expected to continue rallying in the coming months.
Investing.com – U.S. stocks were higher after the close on Friday, as gains in the Utilities, Consumer Services and Telecoms sectors led shares higher. At the close in NYSE, the...
By Yasin Ebrahim Investing.com -- The Dow staged a late-day revival Friday, making a positive start to the third quarter underpinned by a jump in consumer stocks offsetting a...
By Sam Boughedda Morgan Stanley analyst Terence Flynn told investors in a note Friday that Genmab's (NASDAQ:GMAB) announcement of its intent to submit a biologics license...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.